SavedAdd your journal

Journals / Retina-Vitreus / 2017 / Cilt: 26 - Sayı: 4

İntravitreal Enjeksiyon Esnasında Kristalin Lense Uygulanan Kataraktojenik Travmanın İnsidansı ve Cerrahi Yönetimi

The Incidence and Surgical Management of Cataractogenic Trauma that is applied to the Crystalline Lens During Intravitreal Injection

Rıfat RASİER
Amber ŞENEL KÜKNER
Özgür ARTUNAY
Nazlı Gül YALÇIN
Alev KOÇKAR
Halil BAHÇECİOĞLU
Erdal YÜZBAŞIOĞLU
Alper ŞENGÜL
Pages
325–329
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Two of the patients were operated on using the phacoemulsifi cation cataract surgery whereas one patient was operated on with combined phacoemulsifi cation and pars plana vitrectomy.Conclusion: Despite all the precautions taken and maneuvers applied during intravitreal injection, posterior segment surgery may be needed to treat complications afterwards

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study is to report on the incidence and management of iatrogenic cataracts caused by needle penetration of the posterior capsule during intravitreal injection.Material and Methods: 973 phacic patients (1,646 eyes) with age-related macular degeneration who received an intravitreal anti-vascular-endothelial-growth-factor injection were included in this retrospective study.
📊
Key Findings & Data:All the 8,764 intravitreal injections were performed in an offi ce setting.
💡
Conclusion & Impact:Two of the patients were operated on using the phacoemulsifi cation cataract surgery whereas one patient was operated on with combined phacoemulsifi cation and pars plana vitrectomy.Conclusion: Despite all the precautions taken and maneuvers applied during intravitreal injection, posterior segment surgery may be needed to treat complications afterwards
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The aim of this study is to report on the incidence and management of iatrogenic cataracts caused by needle penetration of the posterior capsule during intravitreal injection.Material and Methods: 973 phacic patients (1,646 eyes) with age-related macular degeneration who received an intravitreal anti-vascular-endothelial-growth-factor injection were included in this retrospective study. All the 8,764 intravitreal injections were performed in an offi ce setting. After the clinical appearance of cataracts, a phacoemulsifi cation operation was performed on the patients. Results: Iatrogenic cataracts caused by posterior capsule perforation were identifi ed in three eyes of three patients. One of these three patients was injected with ranibizumab and two patients were injected with bevacizumab. Two of the patients were operated on using the phacoemulsifi cation cataract surgery whereas one patient was operated on with combined phacoemulsifi cation and pars plana vitrectomy.Conclusion: Despite all the precautions taken and maneuvers applied during intravitreal injection, posterior segment surgery may be needed to treat complications afterwards

Özet

Amaç: Bu çalışmanın amacı intravitreal enjeksiyon sırasında posterior kapsül penetrasyonuna bağlı iyatrojenik kataraktların insidansını saptamak ve bu olgulara yaklaşımı sunmaktır. Gereç ve Yöntemler: Yaşa bağlı makula dejenerasyonu (YBMD) olan ve intravitreal anti-vasküler endotelyal growth faktör (anti-VEGF) enjeksiyonu yapılan 973 fakik hastanın 1646 gözü bu retrospektif, çalışmaya alınmıştır. 8764 intravitreal enjeksiyonun tümü ofi s şartlarında gerçekleştirilmiştir. Katarakt kliniği ortaya çıktıktan sonra bu hastalara fakoemülsifi kasyon operasyonu yapılmıştır. Bulgular: Üç hastanın üç gözünde posterior kapsül perforasyonuna bağlı iyatrojenik katarakt saptanmıştır. Üç hastanın bir tanesine ranibizumab ve iki tanesine bevacizumab enjeksiyonu yapılmıştır. Katarakt ameliyatı yapılan hastaların ikisinde komplikasyonsuz fakoemülsifi kasyon cerrahisi yapılmışken bir vakada pars plana vitrektomi ile kombine fakoemülsifi kasyon cerrahisi yapılmıştır. Sonuç: İntravitreal enjeksiyon sırasında alınan tüm önlemlere rağmen sonrasında komplikasyonların tedavisi için arka segment cerrahisi gerekebilir

🔖

Cite This Article

RASİER, R., KÜKNER, A. Ş., ARTUNAY, Ö., YALÇIN, N. G., KOÇKAR, A., BAHÇECİOĞLU, H., YÜZBAŞIOĞLU, E., ŞENGÜL, A. (2017). İntravitreal Enjeksiyon Esnasında Kristalin Lense Uygulanan Kataraktojenik Travmanın İnsidansı ve Cerrahi Yönetimi. Retina-Vitreus, Cilt: 26 - Sayı: 4, 325–329. https://ajindex.com/articles/307605

References (15)

  1. Rosenfeld PJ, Moshfeghi AA, Puliafi to CA. Optical coherence tomography fi ndings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36:331-5
  2. Rosenfeld PJ, Fung AE, Puliafi to CA. Optical coherence tomography fi ndings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-9
  3. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26:275-8
  4. Jager RD, Aiello LP, Patel SC. Risks of intravitreous injection: a comprehensive review. Retina 2004;24:676-98
  5. Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina 2009;29:875-912
  6. Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol 2010;21:178-83
  7. Artunay O, Yuzbasioglu E, Rasier R, et al. Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection. Eye (Lond). 2009;23:2187-93
  8. Rasier R, Artunay O, Yuzbasioglu E, et al. The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension. Eye (Lond). 2009;23:1714-8
  9. Artunay O, Yuzbasioglu E, Rasier R, et al. Posterior reversible encephalopathy syndrome after intravitreal bevacizumab injection in patient with choroidal neovascular membrane secondary to age-related maculopathy. J Ocul Pharmacol Ther. 2010;26:301-3
  10. Meyer CH, Rodrigues EB, Michels S, et al. Incidence of damage to crystalline lens during intravitreal injections. J Ocul Pharmacol Ther. 2010;26:491-5
  11. Smiddy WE, Michels RG, Green WR. Lens and peripheral retinal relationships during vitrectomy. Retina 1991;11:199–203
  12. Chen SD, Mohammed Q, Bowling B, et al. Vitreous wick syndrome–a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. Am. J. Ophthalmol. 2004;137:1159–60
  13. Pulido JS, Pulido CM, Bakri SJ, et al. The use of 31-gauge needles and syringes for intraocular injections. Eye (Lond). 2007;21:829– 30
  14. Hochman MN, Friedman MJ. An in vitro study of needle force penetration comparing a standard linear insertion to the new bidirectional rotation insertion technique. Quintessence Int. 2001;32:789–96
  15. Kozak I, Dean A, Clark TM, et al. Prefi lled syringe needles versus standard removable needles for in